Autologous Transplantation as Consolidation for High Risk Aggressive T-Cell Non-Hodgkin's Lymphoma: A SWOG 9704 Intergroup Trial Subgroup Analysis

Phase II data suggest a benefit to autotransplantation for aggressive T-NHL in first remission; randomized trials have yet to validate this. We performed a retrospective analysis of aggressive T-NHL patients in the intergroup randomized consolidative autotransplant trial (SWOG 9704). Of the 370 enro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Leuk Lymphoma
Autors principals: Al-Mansour, Zeina, Li, Hongli, Cook, James R., Constine, Louis S., Couban, Stephen, Stewart, Douglas A., Shea, Thomas C., Porcu, Pierluigi, Winter, Jane N., Kahl, Brad S., Smith, Sonali M., Marcellus, Deborah C., Barton, Kevin P., Mills, Glenn M., LeBlanc, Michael, Rimsza, Lisa M., Forman, Stephen J., Leonard, John P., Fisher, Richard I., Friedberg, Jonathan W., Stiff, Patrick J.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6620162/
https://ncbi.nlm.nih.gov/pubmed/30628511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2018.1563691
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars